Welcome to our dedicated page for Healthlynked news (Ticker: HLYK), a resource for investors and traders seeking the latest updates and insights on Healthlynked stock.
HealthLynked Corp. (HLYK) provides a cloud-based healthcare connectivity platform transforming patient-provider interactions. This news hub offers investors and healthcare professionals essential updates about the company's strategic initiatives and market position.
Access real-time information on earnings announcements, technology partnerships, and platform enhancements that drive innovation in telemedicine and medical data management. Our curated collection includes press releases about clinical network expansions, regulatory milestones, and operational developments impacting healthcare delivery.
Key updates cover HLYK's progress in patient engagement solutions, EMR integration advancements, and collaborations with healthcare providers. Stay informed about initiatives improving care coordination through AI-driven scheduling tools and secure health data exchange protocols.
Bookmark this page for streamlined access to verified HealthLynked disclosures. Monitor critical developments affecting the company's role in digital healthcare infrastructure without navigating multiple sources.
HealthLynked Corp. (OTCQB: HLYK) reported its financial results for the year and fourth quarter ending December 31, 2022. Revenue fell by 10% to $5.86 million compared to $6.50 million in 2021, primarily due to decreased patient service revenues. An impairment charge of $2.75 million was taken for intangible assets linked to MedOfficeDirect, which has faced declining revenues. However, the company anticipates revenue growth in 2023 from recent initiatives and acquired practices. Net losses decreased to $8.82 million in 2022 from $10.41 million in 2021. The company sold its ACO/MSO business in January 2023 and expects additional payments from this transaction by July 2023.
HealthLynked Corp. announced the granting of Patent No. 11,600,395 by the USPTO for its innovative technology enabling secure patient access via healthcare service provider-specific wireless access points. This patent allows secure communication between patients, providers, and third-party services, enhancing data security and streamlining interactions. CEO Michael Dent emphasized the significance of this milestone in advancing patient-centric solutions in healthcare. The patent positions HealthLynked favorably in the digital healthcare market, offering a competitive edge and facilitating the development of more efficient healthcare services.
HealthLynked (OTCQB: HLYK) announced the appointment of Paul J. Hobaica, MD, to its Board of Directors, succeeding Robert P. Mino, JD, MBA, MS. Dr. Hobaica brings over 25 years of medical experience and serves as Corporate Medical Director at Arthrex Medical Center. His expertise in internal and occupational medicine is expected to enhance HealthLynked's strategic direction, particularly in developing partnerships and services aimed at improving healthcare outcomes. CEO Michael Dent expressed confidence that Dr. Hobaica's leadership will support the company's mission to leverage technology for better healthcare.
FAQ
What is the current stock price of Healthlynked (HLYK)?
What is the market cap of Healthlynked (HLYK)?
